(KNSA) Kiniksa - Performance 32.9% in 12m
Compare KNSA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
16.00%
#24 in Group
Rel. Strength
87.32%
#1010 in Universe
Total Return 12m
32.94%
#29 in Group
Total Return 5y
16.57%
#32 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 2.49%
84th Percentile in Group
12m Total Return: KNSA (32.9%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: KNSA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KNSA
Total Return (including Dividends) | KNSA | XBI | S&P 500 |
---|---|---|---|
1 Month | 34.80% | 2.77% | 5.69% |
3 Months | 32.13% | -14.21% | -6.49% |
12 Months | 32.94% | -14.88% | 9.72% |
5 Years | 16.57% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | KNSA | XBI | S&P 500 |
1 Month | 83.4% | 57% | 89.4% |
3 Months | 52.9% | -82.3% | -72% |
12 Months | 6.50% | -53.1% | 49.3% |
5 Years | 32.8% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #22 | 31.2% | 27.5% |
3 Month | #5 | 54.0% | 41.3% |
12 Month | #28 | 56.2% | 21.2% |
5 Years | #31 | 58.5% | -43.8% |
FAQs
Does KNSA Kiniksa outperforms the market?
Yes,
over the last 12 months KNSA made 32.94%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months KNSA made 32.13%, while XBI made -14.21%.
Over the last 3 months KNSA made 32.13%, while XBI made -14.21%.
Performance Comparison KNSA vs Indeces and Sectors
KNSA vs. Indices KNSA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.45% | 29.1% | 18.1% | 23.2% |
US NASDAQ 100 | QQQ | -6.72% | 27.4% | 17.7% | 22.1% |
US Dow Jones Industrial 30 | DIA | -6.34% | 32.1% | 19.2% | 26.7% |
German DAX 40 | DAX | -6.90% | 19.7% | -7.45% | 8.12% |
Shanghai Shenzhen CSI 300 | CSI 300 | -6.68% | 31.9% | 18.9% | 26.6% |
Hongkong Hang Seng | HSI | -9.33% | 19.9% | 8.64% | 24.7% |
India NIFTY 50 | INDA | -2.75% | 31.6% | 16.2% | 30.9% |
Brasil Bovespa | EWZ | -9.48% | 23.2% | 8.92% | 39.2% |
KNSA vs. Sectors KNSA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.82% | 28.3% | 12.0% | 12.6% |
Consumer Discretionary | XLY | -7.87% | 28.1% | 20.3% | 18.1% |
Consumer Staples | XLP | -5.59% | 34.1% | 11.2% | 25.7% |
Energy | XLE | -8.70% | 30.3% | 24.1% | 42.0% |
Financial | XLF | -7.15% | 28.0% | 12.3% | 11.4% |
Health Care | XLV | -2.35% | 37.9% | 23.4% | 39.0% |
Industrial | XLI | -7.38% | 26.5% | 17.2% | 22.6% |
Materials | XLB | -6.61% | 29.8% | 22.2% | 39.0% |
Real Estate | XLRE | -5.66% | 27.9% | 15.8% | 19.4% |
Technology | XLK | -7.29% | 25.1% | 20.4% | 26.8% |
Utilities | XLU | -7.17% | 29.7% | 10.4% | 16.9% |
Aerospace & Defense | XAR | -6.63% | 25.6% | 8.83% | 6.98% |
Biotech | XBI | 1.27% | 32.0% | 39.2% | 47.8% |
Homebuilder | XHB | -6.09% | 29.2% | 31.8% | 41.8% |
Retail | XRT | -6.51% | 28.7% | 24.4% | 39.2% |